FDA Receives Thousands Of Opinions On Proposal To Regulate LDTs As Comment Period Comes To A Close

As the US FDA works to finalize new regulation of lab-developed tests, it must consider more than two thousand comments that have poured into the agency since the proposed rule was published in October. The comment period closes Monday.